The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 13, 2025
Filed:
Sep. 17, 2021
Applicant:
The Regents of the University of California, Oakland, CA (US);
Inventors:
Gay M. Crooks, Sherman Oaks, CA (US);
Amélie Montel-Hagen, Los Angeles, CA (US);
Christopher Seet, Santa Monica, CA (US);
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, Oakland, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 14/705 (2006.01); C12N 5/0735 (2010.01); C12N 5/074 (2010.01); C12N 5/077 (2010.01); C12N 5/0775 (2010.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0062 (2013.01); A61K 39/4611 (2023.05); A61K 39/4631 (2023.05); A61K 39/4632 (2023.05); A61K 39/4644 (2023.05); A61P 35/00 (2018.01); C07K 14/705 (2013.01); C12N 5/00 (2013.01); C12N 5/0037 (2013.01); C12N 5/0606 (2013.01); C12N 5/0636 (2013.01); C12N 5/0663 (2013.01); C12N 5/0669 (2013.01); C12N 5/0696 (2013.01); C07K 2317/622 (2013.01); C07K 2319/03 (2013.01); C12N 2500/22 (2013.01); C12N 2500/24 (2013.01); C12N 2500/32 (2013.01); C12N 2500/38 (2013.01); C12N 2500/90 (2013.01); C12N 2501/125 (2013.01); C12N 2501/145 (2013.01); C12N 2501/15 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/2304 (2013.01); C12N 2501/2306 (2013.01); C12N 2501/2307 (2013.01); C12N 2501/2315 (2013.01); C12N 2501/2321 (2013.01); C12N 2501/25 (2013.01);
Abstract
Methods and composition for production of T cells are provided. Also provided are therapeutic methods using engineered T cells. For example, in certain aspects methods include preparing three dimensional cell culture compositions comprising stroma cells and hematopoietic stem or progenitor cells in a serum-free medium for producing T cells.
Crooks, Gay. (2025). Methods or generating t-cells from stem cells and immunotherapeutic methods using the t-cells (U.S. Patent No. 12297452). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12297452
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile